We are live on ! Find out more
CRMD icon

CorMedix
CRMD

52 hedge funds and large institutions have $16.2M invested in CorMedix in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 15

0% less capital invested

Capital invested by funds: $16.2M → $16.2M (-$25.3K)

0.25% less ownership

Funds ownership: 4.76% → 4.51% (-0.25%)

4% less funds holding

Funds holding: 54 → 52 (-2)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

96% less call options, than puts

Call options by funds: $49K | Put options by funds: $1.28M

Holders
52
Holders Change
-2
Holders Change %
-3.7%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
18
Reduced
15
Closed
7
Calls
$49K
Puts
$1.28M
Net Calls
-$1.23M
Net Calls Change
+$276K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$139K
2
PAG
Private Advisor Group
New Jersey
+$124K
3
Northern Trust
Northern Trust
Illinois
+$115K
4
ST
Spot Trading
Illinois
+$59.7K
5
VKH
Virtu KCG Holdings
New York
+$59.6K

Top Sellers

Rank Fund Capital Flow
1
PL
Parkwood LLC
Ohio
-$294K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$207K
3
AQR Capital Management
AQR Capital Management
Connecticut
-$189K
4
Morgan Stanley
Morgan Stanley
New York
-$135K
5
UBS Group
UBS Group
Switzerland
-$95.6K

CRMD Hedge Fund Activity: Q4 2015 in Review

52 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2015, worth a combined $16.2M — down 0.16% from $16.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CRMD and 5 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 18 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $139K. The largest seller was Parkwood LLC, exiting entirely with an estimated $294K sold.

  • 52 institutional investors held CorMedix (CRMD) as of Q4 2015, down from 54 in Q3 2015.
  • Funds reported $16.2M of CorMedix stock for Q4 2015, down 0.16% quarter-over-quarter.
  • 5 funds opened new CorMedix positions in Q4 2015 and 7 closed out, a net change of -2 holders.
  • The largest CorMedix buyer in Q4 2015 was Millennium Management, an estimated $139K added.
  • The largest CorMedix seller in Q4 2015 was Parkwood LLC, an estimated $294K sold.

Based on aggregated 13F filings for Q4 2015.